Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 295

1.

"All boats will rise": Physicians' perspectives on multidisciplinary lung cancer care in a community-based hospital setting.

Kedia SK, Ward KD, Collins AC, Jackson BM, Stewart FR, Faris NR, Roark KS, Osarogiagbon RU.

Support Care Cancer. 2019 Jul 15. doi: 10.1007/s00520-019-04950-7. [Epub ahead of print]

PMID:
31309296
2.

Conceptualizing anhedonias and implications for depression treatments.

Winer ES, Jordan DG, Collins AC.

Psychol Res Behav Manag. 2019 May 13;12:325-335. doi: 10.2147/PRBM.S159260. eCollection 2019. Review.

3.

A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.

Shin HJ, Franco LH, Nair VR, Collins AC, Shiloh MU.

PLoS One. 2017 Oct 5;12(10):e0185945. doi: 10.1371/journal.pone.0185945. eCollection 2017.

4.

Bone Accrual in Children and Adolescent Nonelite Swimmers: A 2-Year Longitudinal Study.

Collins AC, Ward KD, McClanahan BS, Slawson DL, Vukadinovich C, Mays KE, Wilson N, Relyea G.

Clin J Sport Med. 2019 Jan;29(1):43-48. doi: 10.1097/JSM.0000000000000484.

PMID:
28708710
5.

Bloody Epiphora (Hemolacria) Years After Repair of Orbital Floor Fracture.

Chon BH, Zhang R, Bardenstein DS, Coffey M, Collins AC.

Ophthalmic Plast Reconstr Surg. 2017 Sep/Oct;33(5):e118-e120. doi: 10.1097/IOP.0000000000000839.

PMID:
27879619
6.

Heme Oxygenase-1 Regulates Inflammation and Mycobacterial Survival in Human Macrophages during Mycobacterium tuberculosis Infection.

Scharn CR, Collins AC, Nair VR, Stamm CE, Marciano DK, Graviss EA, Shiloh MU.

J Immunol. 2016 Jun 1;196(11):4641-9. doi: 10.4049/jimmunol.1500434. Epub 2016 Apr 22.

7.

A comparative approach to assess drivers of success in mammalian conservation recovery programs.

Crees JJ, Collins AC, Stephenson PJ, Meredith HM, Young RP, Howe C, Price MR, Turvey ST.

Conserv Biol. 2016 Aug;30(4):694-705. doi: 10.1111/cobi.12652. Epub 2016 Apr 7.

PMID:
26548375
8.

Cyclic GMP-AMP Synthase Is an Innate Immune DNA Sensor for Mycobacterium tuberculosis.

Collins AC, Cai H, Li T, Franco LH, Li XD, Nair VR, Scharn CR, Stamm CE, Levine B, Chen ZJ, Shiloh MU.

Cell Host Microbe. 2015 Jun 10;17(6):820-8. doi: 10.1016/j.chom.2015.05.005. Epub 2015 Jun 2.

9.

Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus.

Stamm CE, Collins AC, Shiloh MU.

Immunol Rev. 2015 Mar;264(1):204-19. doi: 10.1111/imr.12263. Review.

10.

Presynaptic GABAB autoreceptor regulation of nicotinic acetylcholine receptor mediated [(3)H]-GABA release from mouse synaptosomes.

McClure-Begley TD, Grady SR, Marks MJ, Collins AC, Stitzel JA.

Biochem Pharmacol. 2014 Sep 1;91(1):87-96. doi: 10.1016/j.bcp.2014.06.010. Epub 2014 Jun 19.

11.

The hepatitis C crisis in the African American Community: findings and recommendations.

Bailey RK, Muir AJ, Howell CD, Bright C, Roane PR, Teshale E, Johnson CM, Curry SB, Collins AC, Jordan W, Allison-Ottey SD.

J Natl Med Assoc. 2013 Summer;105(2):108-11. Review. No abstract available.

PMID:
24079211
12.

The ubiquitin ligase parkin mediates resistance to intracellular pathogens.

Manzanillo PS, Ayres JS, Watson RO, Collins AC, Souza G, Rae CS, Schneider DS, Nakamura K, Shiloh MU, Cox JS.

Nature. 2013 Sep 26;501(7468):512-6. doi: 10.1038/nature12566. Epub 2013 Sep 4.

13.

Oral Nicotine Self-Administration in Rodents.

Collins AC, Pogun S, Nesil T, Kanit L.

J Addict Res Ther. 2012 Jun 1;S2. pii: 004.

14.

Comparison of nutritional intake in US adolescent swimmers and non-athletes.

Collins AC, Ward KD, Mirza B, Slawson DL, McClanahan BS, Vukadinovich C.

Health (Irvine Calif). 2012 Oct;4(10):873-880.

15.

Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures.

Zambrano CA, Salamander RM, Collins AC, Grady SR, Marks MJ.

J Pharmacol Exp Ther. 2012 Aug;342(2):245-54. doi: 10.1124/jpet.112.192542. Epub 2012 Apr 24.

16.

A novel α-conotoxin MII-sensitive nicotinic acetylcholine receptor modulates [(3) H]-GABA release in the superficial layers of the mouse superior colliculus.

McClure-Begley TD, Wageman CR, Grady SR, Marks MJ, McIntosh JM, Collins AC, Whiteaker P.

J Neurochem. 2012 Jul;122(1):48-57. doi: 10.1111/j.1471-4159.2012.07759.x. Epub 2012 May 9.

17.

Individual differences in oral nicotine intake in rats.

Nesil T, Kanit L, Collins AC, Pogun S.

Neuropharmacology. 2011 Jul-Aug;61(1-2):189-201. doi: 10.1016/j.neuropharm.2011.03.027. Epub 2011 Apr 12.

18.

Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain.

Marks MJ, McClure-Begley TD, Whiteaker P, Salminen O, Brown RW, Cooper J, Collins AC, Lindstrom JM.

J Pharmacol Exp Ther. 2011 Apr;337(1):187-200. doi: 10.1124/jpet.110.178236. Epub 2011 Jan 12.

19.

86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization.

Marks MJ, Meinerz NM, Brown RW, Collins AC.

Biochem Pharmacol. 2010 Oct 15;80(8):1238-51. doi: 10.1016/j.bcp.2010.06.040. Epub 2010 Jun 30.

20.

Mouse striatal dopamine nerve terminals express alpha4alpha5beta2 and two stoichiometric forms of alpha4beta2*-nicotinic acetylcholine receptors.

Grady SR, Salminen O, McIntosh JM, Marks MJ, Collins AC.

J Mol Neurosci. 2010 Jan;40(1-2):91-5. doi: 10.1007/s12031-009-9263-y. Epub 2009 Aug 20.

21.

John Daly's compound, epibatidine, facilitates identification of nicotinic receptor subtypes.

Marks MJ, Laverty DS, Whiteaker P, Salminen O, Grady SR, McIntosh JM, Collins AC.

J Mol Neurosci. 2010 Jan;40(1-2):96-104. doi: 10.1007/s12031-009-9264-x. Epub 2009 Aug 12.

22.

Pharmacological and immunochemical characterization of alpha2* nicotinic acetylcholine receptors (nAChRs) in mouse brain.

Whiteaker P, Wilking JA, Brown RW, Brennan RJ, Collins AC, Lindstrom JM, Boulter J.

Acta Pharmacol Sin. 2009 Jun;30(6):795-804. doi: 10.1038/aps.2009.68.

23.

The road to discovery of neuronal nicotinic cholinergic receptor subtypes.

Collins AC, Salminen O, Marks MJ, Whiteaker P, Grady SR.

Handb Exp Pharmacol. 2009;(192):85-112. doi: 10.1007/978-3-540-69248-5_4. Review.

PMID:
19184647
24.

Acetylcholine-stimulated [3H]GABA release from mouse brain synaptosomes is modulated by alpha4beta2 and alpha4alpha5beta2 nicotinic receptor subtypes.

McClure-Begley TD, King NM, Collins AC, Stitzel JA, Wehner JM, Butt CM.

Mol Pharmacol. 2009 Apr;75(4):918-26. doi: 10.1124/mol.108.052274. Epub 2009 Jan 12.

25.

Guest editorial. Genes and lung cancer.

Collins AC, McQueen M, Ehringer M.

Hum Genomics. 2008 Sep;3(1):3-6. No abstract available.

26.

The fused TrpEG from Streptomyces venezuelae is an anthranilate synthase, not a 2-amino-2-deoxyisochorismate [corrected] (ADIC) synthase.

Ashenafi M, Carrington R, Collins AC, Byrnes WM.

Ethn Dis. 2008 Spring;18(2 Suppl 2):S2-9-13. Erratum in: Ethn Dis. 2012 Autumn:22(4):530.

27.

Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.

Gotti C, Moretti M, Meinerz NM, Clementi F, Gaimarri A, Collins AC, Marks MJ.

Mol Pharmacol. 2008 Jun;73(6):1796-807. doi: 10.1124/mol.108.045203. Epub 2008 Mar 12.

PMID:
18337473
28.

Synthesis and characterization of 125I-alpha-conotoxin ArIB[V11L;V16A], a selective alpha7 nicotinic acetylcholine receptor antagonist.

Whiteaker P, Marks MJ, Christensen S, Dowell C, Collins AC, McIntosh JM.

J Pharmacol Exp Ther. 2008 Jun;325(3):910-9. doi: 10.1124/jpet.108.136895. Epub 2008 Mar 6.

PMID:
18323456
29.

Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice.

Adams CE, Yonchek JC, Zheng L, Collins AC, Stevens KE.

Brain Res. 2008 Feb 15;1194:138-45. doi: 10.1016/j.brainres.2007.12.007. Epub 2007 Dec 8.

30.

The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults.

Schlaepfer IR, Hoft NR, Collins AC, Corley RP, Hewitt JK, Hopfer CJ, Lessem JM, McQueen MB, Rhee SH, Ehringer MA.

Biol Psychiatry. 2008 Jun 1;63(11):1039-46. doi: 10.1016/j.biopsych.2007.10.024. Epub 2007 Dec 27. Erratum in: Biol Psychiatry. 2011 May 1;69(9):905-6.

31.

The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco.

Zeiger JS, Haberstick BC, Schlaepfer I, Collins AC, Corley RP, Crowley TJ, Hewitt JK, Hopfer CJ, Lessem J, McQueen MB, Rhee SH, Ehringer MA.

Hum Mol Genet. 2008 Mar 1;17(5):724-34. Epub 2007 Nov 30.

PMID:
18055561
32.

The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC, Marks MJ.

Biochem Pharmacol. 2007 Oct 15;74(8):1235-46. Epub 2007 Jul 27. Review.

33.

Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.

Nashmi R, Xiao C, Deshpande P, McKinney S, Grady SR, Whiteaker P, Huang Q, McClure-Begley T, Lindstrom JM, Labarca C, Collins AC, Marks MJ, Lester HA.

J Neurosci. 2007 Aug 1;27(31):8202-18.

35.

Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers.

Brown RW, Collins AC, Lindstrom JM, Whiteaker P.

J Neurochem. 2007 Oct;103(1):204-15. Epub 2007 Jun 15.

36.

Cloning and expression of streptomycin inactivating enzymes APH(6)-Ia and APH(6)-Id.

Collins AC, Ashenafi M, Saunders AA, Byrnes WM.

Cell Mol Biol (Noisy-le-grand). 2007 May 15;53(3):74-9.

PMID:
17531152
37.

Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice.

Booker TK, Butt CM, Wehner JM, Heinemann SF, Collins AC.

Pharmacol Biochem Behav. 2007 May;87(1):146-57. Epub 2007 Apr 21.

PMID:
17509676
38.

Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice.

Damaj MI, Fonck C, Marks MJ, Deshpande P, Labarca C, Lester HA, Collins AC, Martin BR.

J Pharmacol Exp Ther. 2007 Jun;321(3):1161-9. Epub 2007 Mar 19.

PMID:
17371806
39.

Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice.

Salminen O, Drapeau JA, McIntosh JM, Collins AC, Marks MJ, Grady SR.

Mol Pharmacol. 2007 Jun;71(6):1563-71. Epub 2007 Mar 6.

PMID:
17341654
40.

Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine.

Ehringer MA, Clegg HV, Collins AC, Corley RP, Crowley T, Hewitt JK, Hopfer CJ, Krauter K, Lessem J, Rhee SH, Schlaepfer I, Smolen A, Stallings MC, Young SE, Zeiger JS.

Am J Med Genet B Neuropsychiatr Genet. 2007 Jul 5;144B(5):596-604.

PMID:
17226798
41.

Immunolabeling demonstrates the interdependence of mouse brain alpha4 and beta2 nicotinic acetylcholine receptor subunit expression.

Whiteaker P, Cooper JF, Salminen O, Marks MJ, McClure-Begley TD, Brown RW, Collins AC, Lindstrom JM.

J Comp Neurol. 2006 Dec 20;499(6):1016-38.

PMID:
17072836
42.

Guidelines on nicotine dose selection for in vivo research.

Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM, Zirger JM.

Psychopharmacology (Berl). 2007 Feb;190(3):269-319. Epub 2006 Aug 9. Review.

PMID:
16896961
43.
44.

The pathophysiology of traumatic brain injury in alpha7 nicotinic cholinergic receptor knockout mice.

Kelso ML, Wehner JM, Collins AC, Scheff SW, Pauly JR.

Brain Res. 2006 Apr 14;1083(1):204-10. Epub 2006 Mar 20.

PMID:
16545784
45.

Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4* nicotinic receptors.

Fonck C, Cohen BN, Nashmi R, Whiteaker P, Wagenaar DA, Rodrigues-Pinguet N, Deshpande P, McKinney S, Kwoh S, Munoz J, Labarca C, Collins AC, Marks MJ, Lester HA.

J Neurosci. 2005 Dec 7;25(49):11396-411.

46.

Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation.

McCallum SE, Collins AC, Paylor R, Marks MJ.

Psychopharmacology (Berl). 2006 Mar;184(3-4):314-27. Epub 2005 Jul 2.

PMID:
16001112
47.

The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay.

Salminen O, Whiteaker P, Grady SR, Collins AC, McIntosh JM, Marks MJ.

Neuropharmacology. 2005 Apr;48(5):696-705.

PMID:
15814104
48.

Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol.

Bowers BJ, McClure-Begley TD, Keller JJ, Paylor R, Collins AC, Wehner JM.

Alcohol Clin Exp Res. 2005 Mar;29(3):295-302.

PMID:
15770102
49.

Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.

Gotti C, Moretti M, Clementi F, Riganti L, McIntosh JM, Collins AC, Marks MJ, Whiteaker P.

Mol Pharmacol. 2005 Jun;67(6):2007-15. Epub 2005 Mar 4.

PMID:
15749993
50.

Modulation of nicotine but not ethanol preference by the mouse Chrna4 A529T polymorphism.

Butt CM, King NM, Hutton SR, Collins AC, Stitzel JA.

Behav Neurosci. 2005 Feb;119(1):26-37.

PMID:
15727510

Supplemental Content

Loading ...
Support Center